A randomised controlled trial of Eutectic Mixture of Lidocaine and Prilocaine (EMLA) cream as a primary dressing for painful chronic leg ulcers: A pilot study.
- Conditions
- Reduction of pain in lower leg ulcers.Anaesthesiology - Pain management
- Registration Number
- ACTRN12609001080213
- Lead Sponsor
- Central Coast Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Patient has one or more chronic lower leg ulcer(s) of at least 6 weeks duration and up to 100cm2 in size in total.
Patients with low to moderate wound exudate.
Numerical Rating Scale pain score = 4 at assessment and/or within the previous week.
Patients currently requiring oral analgesics due to previously reported wound-related pain.
Patients have the capacity to consent to participation.
Patients have the capacity to attend the Community Nursing Procedure clinics.
Patients scheduled for leg amputation.
History of peripheral sensory neuropathy of the feet.
Patients that have had or require the use of EMLA cream for debridement of the wound bed within the previous 4 weeks.
Patients with suspected wound malignancy or pyoderma gangrenosum, confirmed by biopsy.
Patients with diagnosed localized or spreading clinical wound infection.
End stage palliative care patients.
Allergy to EMLA cream and/or history of local anesthetic drug sensitivity
A history of congenital or idiopathic methemoglobinemia
Patients on Class III anti-arrhythmic drugs.
Severe hepatic disease.
Pregnant and/or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method